DRAMAMINE- dimenhydrinate tablet
Navajo Manufacturing Company Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
for prevention and treatment of these symptoms associated with motion sickness:
• nausea • vomiting • dizziness
• a breathing problem such as emphysema or chronic bronchitis
• glaucoma
• trouble urinating due to an enlarged prostate gland
to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity
to prevent or treat motion sickness:
adults and children 12 years and over |
• take 1 to 2 chewable tablets every 4-6 hours • do not take more than 8 chewable tablets in 24 hours, or as directed by a doctor |
children 6 to under 12 years |
• give 1/2 to 1 chewable tablet every 6-8 hours • do not give more than 3 chewable tablets in 24 hours, or as directed by a doctor |
children 2 to under 6 years |
• give 1/2 chewable tablet every 6-8 hours • do not give more than 1-1/2 chewable tablets in 24 hours, or as directed by a doctor |
•
Phenylketonurics: contains phenylalanine 0.84 mg per tablet
• store at room temperature 20º-25ºC (68º- 77ºF)
• do not use if pouch is opened
• see pouch for lot number and expiration date
DRAMAMINE
dimenhydrinate tablet |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - Navajo Manufacturing Company Inc. (091917799) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Navajo Manufacturing Company Inc. | 136941411 | relabel(67751-170) , repack(67751-170) |